SANDFORD D. SMITH

Corporate Board Profile

Tech Score: 0/100

CSP INC /MA/

Filing Date	Source Excerpt
2002-12-26	Sandford D. Smith (55) . . . . . . . . . . . Director of CSPI since 1993; President of Therapeutics International of Genzyme Corp., a biopharmaceutical company, since February 1997; President of Specialty Therapeutics of Genzyme Corp., from April 1996 to February 1997; President and Chief Executive Officer of Repligen Corporation from 1987 to 1996; Director of Ariad Pharmaceuticals, Inc. and Chemex Pharmaceuticals, Inc. The Audit Committee consists of Messrs. James, Smith and Williams. The Compensation Committee consists of Messrs. Lyons, James and Smith.

Filing Date

Source Excerpt

2002-12-26

Sandford D. Smith (55) . . . . . . . . . . . Director of CSPI since 1993; President of Therapeutics International of Genzyme Corp., a biopharmaceutical company, since February 1997; President of Specialty Therapeutics of Genzyme Corp., from April 1996 to February 1997; President and Chief Executive Officer of Repligen Corporation from 1987 to 1996; Director of Ariad Pharmaceuticals, Inc. and Chemex Pharmaceuticals, Inc. The Audit Committee consists of Messrs. James, Smith and Williams. The Compensation Committee consists of Messrs. Lyons, James and Smith.

Data sourced from SEC filings. Last updated: 2025-08-30